Annual EBITDA
-$32.78 M
-$12.42 M-61.00%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual EBITDA is -$32.78 million, with the most recent change of -$12.42 million (-61.00%) on December 31, 2023.
- During the last 3 years, EFTR annual EBITDA has fallen by -$48.84 million (-304.18%).
- EFTR annual EBITDA is now -286.40% below its all-time high of $17.59 million, reached on December 31, 2021.
Performance
EFTR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$8.06 M
+$285.00 K+3.42%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly EBITDA is -$8.06 million, with the most recent change of +$285.00 thousand (+3.42%) on March 31, 2024.
- Over the past year, EFTR quarterly EBITDA has increased by +$1.24 million (+13.34%).
- EFTR quarterly EBITDA is now -141.22% below its all-time high of $19.54 million, reached on December 31, 2021.
Performance
EFTR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$31.54 M
+$1.24 M+3.78%
March 31, 2024
Summary
- As of February 8, 2025, EFTR TTM EBITDA is -$31.54 million, with the most recent change of +$1.24 million (+3.78%) on March 31, 2024.
- Over the past year, EFTR TTM EBITDA has increased by +$1.67 million (+5.03%).
- EFTR TTM EBITDA is now -215.08% below its all-time high of $27.41 million, reached on March 31, 2022.
Performance
EFTR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EFTR EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.0% | +13.3% | +5.0% |
| 3 y3 years | -304.2% | +13.3% | +5.0% |
| 5 y5 years | -304.2% | +13.3% | +5.0% |
EFTR EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -286.4% | at low | -141.2% | +13.3% | -215.1% | +8.4% |
| 5 y | 5-year | -286.4% | at low | -141.2% | +13.3% | -215.1% | +8.4% |
| alltime | all time | -286.4% | at low | -141.2% | +13.3% | -215.1% | +8.4% |
EFFECTOR Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$8.06 M(-3.4%) | -$31.54 M(-3.8%) |
| Dec 2023 | -$32.78 M(+61.0%) | -$8.34 M(+10.8%) | -$32.78 M(-0.6%) |
| Sep 2023 | - | -$7.53 M(-1.2%) | -$32.98 M(-4.2%) |
| Jun 2023 | - | -$7.62 M(-18.1%) | -$34.42 M(+3.6%) |
| Mar 2023 | - | -$9.30 M(+8.9%) | -$33.21 M(+63.1%) |
| Dec 2022 | -$20.36 M | -$8.54 M(-4.8%) | -$20.36 M(-363.8%) |
| Sep 2022 | - | -$8.97 M(+40.0%) | $7.72 M(-70.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.41 M(-280.4%) | $26.06 M(-4.9%) |
| Mar 2022 | - | $3.55 M(-81.8%) | $27.41 M(+55.8%) |
| Dec 2021 | $17.59 M(+9.5%) | $19.54 M(+108.5%) | $17.59 M(-335.6%) |
| Sep 2021 | - | $9.37 M(-285.2%) | -$7.46 M(-69.0%) |
| Jun 2021 | - | -$5.06 M(-19.3%) | -$24.10 M(+26.6%) |
| Mar 2021 | - | -$6.27 M(+13.8%) | -$19.04 M(+49.1%) |
| Dec 2020 | $16.05 M | -$5.51 M(-24.2%) | -$12.77 M(+75.8%) |
| Sep 2020 | - | -$7.26 M | -$7.26 M |
FAQ
- What is eFFECTOR Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual EBITDA year-on-year change?
- What is eFFECTOR Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly EBITDA year-on-year change?
- What is eFFECTOR Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM EBITDA year-on-year change?
What is eFFECTOR Therapeutics annual EBITDA?
The current annual EBITDA of EFTR is -$32.78 M
What is the all time high annual EBITDA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual EBITDA is $17.59 M
What is eFFECTOR Therapeutics annual EBITDA year-on-year change?
Over the past year, EFTR annual EBITDA has changed by -$12.42 M (-61.00%)
What is eFFECTOR Therapeutics quarterly EBITDA?
The current quarterly EBITDA of EFTR is -$8.06 M
What is the all time high quarterly EBITDA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly EBITDA is $19.54 M
What is eFFECTOR Therapeutics quarterly EBITDA year-on-year change?
Over the past year, EFTR quarterly EBITDA has changed by +$1.24 M (+13.34%)
What is eFFECTOR Therapeutics TTM EBITDA?
The current TTM EBITDA of EFTR is -$31.54 M
What is the all time high TTM EBITDA for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM EBITDA is $27.41 M
What is eFFECTOR Therapeutics TTM EBITDA year-on-year change?
Over the past year, EFTR TTM EBITDA has changed by +$1.67 M (+5.03%)